Revival Hydration offers mobile IV drips for hydration, energy, immunity, recovery, food poisoning support, hangover relief, NAD+ therapy, Myers Cocktail, beauty support, and more
Colorectal cancer metastatic dMMR immuno-therapy (COMMIT) study: A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC)NRG-GI004/SWOG-S1610
Professional microneedling treatments followed by copper peptide application can produce results exceeding either treatment alone
Going forward, additional research could include larger, long-term clinical trials to determine if peptide therapy benefits extend beyond AMH numbers, like supporting live birth rates or overall ovarian health
Net Quantity: 60 count